Sajid Javid has requested a rapid high-level review of the market for PCR travel tests
News
Moderna’s COVID-19 vaccine maintains antibodies to six months, study shows
Variants studied included Alpha, Beta, Gamma, Delta, Epsilon and Iota
FDA approval for Xywav for idiopathic hypersomnia in adults
First and only FDA-approved treatment for the neurological sleep disorder
Entry closing next month for the 2021 Communications Awards
The 2021 Communications Awards will be closing its doors for entry on the 10th of September.
FDA approves Keytruda plus Lenvima for advanced kidney cancer
Combination treatment reduced the risk of disease progression or death by 61% versus Sutent
US rejects AZ and FibroGen’s anaemia drug roxadustat
FDA has requested an additional clinical trial on the safety of roxadustat
Further clinical trial planned for Valneva’s COVID-19 vaccine candidate
Trial will aim to generate additional safety and immunogenicity data
NICE recommends Eli Lilly’s breast cancer drug Verzenios
Cost-effectiveness watchdog initially rejected the drug in February
Takeda takes the lead on Finch’s ulcerative colitis candidate FIN-524
The clinical development programme is now known as TAK-524
bluebird bio re-evaluates gene therapy strategy in ‘untenable’ European market
US biotech company says European payers have ‘not yet evolved their approach to gene therapy’
New joint venture aims to ‘open’ funding opportunities for early medicines discovery
Collaboration will drive medicines discovery in areas of unmet patient need
MHRA nod for Janssen’s relapsing multiple sclerosis drug Ponvory
Phase III trial showed a reduction in annual relapse rate
Santen and Sydnexis partner on childhood myopia treatment SYD-101
Phase III trials are ongoing in Europe and the US
SMC approves Bavencio for bladder cancer
The treatment was not recommended by NICE for the NHS in England
UK approval for Epidyolex to treat seizures from tuberous sclerosis
Approval represents a new indication for GW’s cannabidiol in the UK
